66 results about "Intravenous drug" patented technology

A method and apparatus for delivering intravenous drugs to a patient provides for remote loading and programming of IV pumps that may be shipped in a loaded and programmed configuration to a remote site for use with the patient. A special carrier may be provided for pneumatic delivery of the preloaded pump. Password enabled customizing of pump features according to specific user's need may be provided to prevent undesired changing of the pump parameters at the remote site.

An intravenous drug access system. In one embodiment of the invention, the drug access system includes an IV bag having an inlet port and outlet port, whereby the inlet port is a female luer integral therewith. The integral female luer fitting may be fitted with a sealed end cap comprising a male luer insert with a closed end. An alternative embodiment of the present invention comprises a discrete pre-molded connector made with one spike at one end and a female luer fitting at the opposing end. The spike is used to penetrate a standard IV bag through a conventional inlet port.

The invention relates to the technical field of medicine, which is a preparation of a taxane drug for intravenous drug delivery, consisting of two parts of drug solution and an emulsion. The drug solution is composed of paclitaxel or docetaxel, a pH regulator and a solvent for injection, wherein, the solvent for injection is an organic solvent; the emulsion comprises a fat emulsion and is composed of oil for injection, an emulsifier, an antioxidant, an isotonic regulator, a stabilizer, a pH regulator and water for injection. When in use, the drug solution can be added and evenly mixed in the emulsion for direct intravenous drip according to the clinical drug dosage and can also be firstly added in the emulsion with the volume that is not less than 5 times of the volume of the drug solution according to the clinical drug dosage and then added with a certain amount of physiological saline or glucose injection for intravenous drip. The preparation of the invention does not contain solubilizer and has the advantages of little toxicity, safety, effectivity, stability and economy. The fat emulsion can also be taken as a nutrition replenisher for a patient, thus achieving better treatment effects. The physiological saline or the glucose injection can also replace a certain amount of the emulsion, so the storage and the transportation are convenient, and the preparation is more economical.

The present invention provides a highly automated puncture system for inserting a cannula or a needle into a blood vessel of a person or an animal. The puncture system has an acquisition module that allows for determining at least a location of a blood vessel underneath of the surface of a skin and is further enabled to determine an optimal puncture location that is well suitable for inserting a cannula into the blood vessel. Further, the puncture system has an actuator for moving and aligning the cannula to a determined position. The system is further adapted to autonomously insert the cannula into the blood vessel for multiple purposes, such as blood withdrawal, venous medication and infusions.

The invention discloses a slow-release microsphere preparation containing a recombined human haemopoietin. The slow-release microsphere preparation is prepared by the S/O/W compound emulsion solvent volatilization method. The preparation method comprises that: firstly, by the freeze-drying method, a micro particle containing the human serum albumin and the recombined human haemopoietin is prepared; secondly, by using a biodegradable high molecular material of lactic acid-glycollic acid block copolymer as a carrier material, the micro particle containing the human serum albumin and the recombined human haemopoietin is encapsulated; and thirdly, the lactic acid-glycollic acid block copolymer slow-release microsphere preparation containing the recombined human haemopoietin is prepared. The microsphere of the invention has the advantages of smooth surface, uniform appearance, regular size and no adhesion, the average particle size is between 70 and 105mu m; moreover, the microsphere is high in drug-carrying quantity and encapsulating rate, and the in vitro slow release period is more than 30 days. The obtained slow-release microsphere preparation is good in biocompatibility and can be used for non-intravenous drug administration such as hypodermic drug administration and intramuscular drug administration, and when used as a drug preparation for treating renal anemia, the slow-release microsphere preparation can improve the hematocrit of a patient.

The present invention relates to a system for computer-aided intravenous delivery of anesthetics and/or other drugs to a patient, wherein said system comprises an Infusion Controller that delivers an amount of drug(s) to a patient; possibly a DataLogger Controller with one or more Sensors adapted so as to be coupled to a patient and to generate signals reflecting one or more health conditions or statuses of the patient; a Communication Controller connected with the infusion pumps and/or monitors; a Session Controller that carries out the modeling of anesthesia procedures and is arranged to run a first procedure and to dynamically adapt said first procedure and/or select and run a second procedure based upon one or more of said sensors' output and/or observation from a physician; a Graphic User Interface to display different views of the system and to accept user input; a set of interfaces used to link the Infusion, Datalogger and Session Controllers to views displayed by the Graphical User Interface; a Processor or Infusion Session Manager that integrates the Graphic User Interface, the Infusion Controller, the DataLogger Controller, the Communication Controller and the Session Controller and that steers drug delivery, wherein the system contains a set of configurable written procedures to steer intravenous anesthetic drag delivery and/or other drug delivery, whereby said procedures have been adapted to the type of surgical action and/or therapy, adapted to the patient's physical condition, and adapted to the type of drugs, tools and theoretical models used. The system of the present invention finds its use among others in intravenous anesthesia (IVA) and in cancer therapy.

The invention discloses a device for blending medical vein medicines. The device comprises a baseplate, a clamp, a bottleneck scribing mechanism, a bottle opener, a liquid absorption and injection device, a medicinal oscillator and an administration device. The device aims to overcome the defect of low efficiency of blending medicines mutually in the prior art. According to the device, the baseplate is fixed to a platform in a biological safety cabinet; ampoules and a seal bottle clamp group are arranged on the baseplate; bottlenecks of ampoules of different specifications are scribed by a horizontal expansion piece and a vertical expansion piece; the liquid absorption and injection device and an air cylinder piston rod are fixed with a fixed plate of an injector piston rod by a screw cap; and an injector group is inserted into the fixed plate of the injector piston rod and a groove on a fixed plate of an injection vat. According to the device, manual operation is replaced by a linkage structure to realize the medicine blending processes of the absorption and injection of liquid medicine, dissolution by vibration and administration. The invention has the advantages that the device is convenient to use and economic and is operated by power in the process, and blending efficiency of the medicines is improved greatly. The device is suitable to be applied to vein medicine blending centers of hospitals.

The invention belongs to the technical field of medicines, and relates to honokiol nanoparticles and a preparation method thereof. The honokiol nanoparticles are prepared by adopting an ultrasonic-precipitation method in combination with a freeze-drying technology, and the composition of prescription is as follows: the combination ratio of honokiol to a stabilizer is 1:(0.05-50). According to the honokiol nanoparticles and the preparation method thereof, through prescription optimization, povidone (PVP) and bovine serum albumin (BSA) are screened as the best stabilizer combination. The prepared honokiol nanoparticles are high in drug loading, stable in nature, simple in prescription composition, easy, convenient and feasible in preparation process, and the particle size range is 100nm-300nm; and through the preparation of the nanoparticles, the dissolution of honokiol can be obviously promoted, the oral bioavailability is improved, and tissue distribution in the body is improved. In addition, the honokiol nanoparticles can be freeze-dried, and a suitable excipient is added into the obtained freeze-dried powder for further preparing different dosage forms such as oral liquid, tablets, granules and capsules, and also can be prepared into injection for subcutaneous, muscle or intravenous drug delivery so as to be convenient for clinical application.

A system for monitoring a concentration of an anesthetic drug using a patient's breath is provided. The system comprises a sampling subsystem for processing the patient's breath to form a breath sample, one or more sensors to measure drug concentration in the breath sample, one or more sensors to measure a concentration of gases in the breath sample; and one or more microprocessors for determining a concentration of the drug in a plasma of the patient using a transfer function and the concentration of the drug in the breath sample. A system for monitoring propofol concentration in patient's breath sample is also provided.

The invention relates to moxifloxacin hydrochloride glucose injection and the preparation method thereof. The preparation method comprises the following steps: A. adding injection water into the ingredient tank and a proper amount of auxiliary material and ibuprofen, B. stirring and adjusting the PH value with base regulator to 6.5 - 9.0. Adding injection water to the needed amount and stirring by activated carbon pole for needle injection, decarbonising the titanium stick and refine the solution by millipore filter. C. conducting the encapsulation after the pass of the test. D. delivering the encapsulated semi-product into the sterilization case for autoclave sterilization.

Described herein are devices, systems, and methods for determining the composition of liquids, including the identity of one or more drugs in the liquid, the concentration of the drug, and the type of diluent using immittance spectroscopy. These devices, systems and methods are particularly useful for describing the identity and, in some variations, concentration of one or more components of a medical liquid such as intravenous fluid. In particular, described herein are devices, systems and methods that may operate in low ionic strength diluents. Also described are methods of recognizing complex immittance spectrograph patterns to determine the composition of a liquid by pattern recognition.

The invention relates to a venous medicine dispensing unit, which relates to the medical equipment technology field. The venous medicine dispensing unit is a series of sequentially arranged cabinets including at least one raw medicines storage cabinet, at least one raw perfusion storage cabinet, at least one venous medicine dispensing cabinet, and at least one dispensed venous medicines storage cabinet. The unit is clean on mixing and storing medicines and including later arranging. The unit comprises advantages including reasonable structure, low cost, clean, safe and fast mixing process. The unit comprises the reasonable arrangement of the present room of the hospital, so as to reduce the risk of the medicine waste and outside pollution. The venous medicine dispensing unit can be used for clean and safe mixing of vein in every grade hospitals.

A multiple intravenous line organizer for managing multiple intravenous lines which provide a mechanism for labeling each line, prevent the lines from tangling, and place the injection port in an accessible position thereby preventing errors associated with simultaneous multiple intravenous drug infusion.

The invention discloses an intelligent biology purification and isolation shelter, which comprises a closed modular main shelter, a closed modular sub-shelter, a wind leaching purification system, anair purification air supply system and an air purification negative pressure system. A closed clean protection area is formed in the closed modular main shelter, and a folding medical bed is arrangedin the closed clean protection area; and the wind leaching purification system is arranged in the closed modular sub-shelter, the closed modular main shelter is provided with the air purification negative pressure system, the closed modular main shelter and the closed modular sub-shelter are independent of each other, and a main shelter efficient filter is arranged in the air purification negativepressure system. The negative pressure medical purification and isolation shelter adopts the two sets of air purification systems, air purification of the wind leaching systems in the main shelter and the sub-shelter reaches the standard, harmful drug odor, powder, particles, volatile substances and the like are filtered and discharged during intravenous drug dispensing or human isolation, and thus the space in the shelter achieves sterile, non-particle and non-odor purification.

The invention discloses an automatic batch division method for an intravenous drug dispensing center. The method is based on a computer and comprises the following steps: a plurality of preset batchesare divided according to preset time periods every day; the computer receives various intravenous medication information and judges whether the information belongs to temporary doctor's advice or long-term doctor's advice respectively; according to the preset batch division rules, the computer automatically divides each corresponding batch of each intravenous medication information belonging to the temporary doctor's advice into each preset batch on the same day; according to the preset batch division rules, the computer divides each planned batch of each intravenous medication information belonging to the long-term doctor's advice and automatically divides all planned batches of all intravenous medication information belonging to the long-term doctor's advice into each preset batch on each date. Thereby, automatically divide the intravenous medication batches are automatically divided, working efficiency of the intravenous drug dispensing center is improved, the error probability isreduced.

The invention provides a potato and magnesium sulfate composition wet compressing bag and relates to the technical field of auxiliary medical appliances. The potato and magnesium sulfate composition wet compressing bag comprises a bag body and is characterized in that a detumescence medium is held in the bag body; the detumescence medium consists of potato freeze-dried powder and magnesium sulfate powder. The potato and magnesium sulfate composition wet compressing bag provided by the invention not only is rapid in curative effect, rapid in pain stopping effect, effective in treatment and short in required time and is capable of relieving the pains of patients when being used for performing wet compressing treatment on swelling and phlebophlogosis which are caused by intravenous drug extravasation but also is convenient in use, low in price and simple and easy in operation, and can be easily accepted by family members and the patients.

The invention discloses an integrated management system and method for an intravenous drug configuration center. The system comprises an electronic tag identification system, an air supply managementsystem and a video management system, the electronic tag identification system, the air supply management system and the video management system are connected with a core switch through a first switch, a second switch and a third switch respectively, and the core switch is connected with a background server and a client PC. An RFID radio frequency identification technology is adopted in the wholeprocess; full-process comprehensive and accurate management is achieved, information asymmetry among inpatient areas is reduced, it is ensured that a large number of infusion drugs have no errors on asupply chain, data support is provided for responsibility management enhancement, responsibility traceability is achieved, performance distribution is reasonably conducted, the department managementlevel is enhanced, and the situations of drug missed distribution, missed delivery, wrong delivery and the like are avoided. An air supply management system based on the Internet of Things is furtherarranged, the dispensing chamber is kept in a pollution-free, safe and comfortable environment, and dispensing safety is guaranteed.

The invention relates to a drug dispensing robot. The drug dispensing robot is used for automatic dispensing of venous drugs of penicillin bottles. The drug dispensing robot comprises a base platform,a mother liquid bag clamping device, a penicillin bottle clamping device, a suction and injection device and a disinfecting device, wherein the mother liquid bag clamping device is used for clampingmother liquid bags different in size; the penicillin bottle clamping device is used for clamping penicillin bottles different in size; the suction and injection device is used for making an injectionsyringe switched back and forth between a suction high position of the mother liquid bags and a suction high position of the penicillin bottles so as to perform puncture, suction and injection operation of the injection syringe; and the disinfecting device is used for disinfecting penicillin bottles on a drug storage rotating disk in a pick-and-place low position. The drug dispensing robot can carry out a continuous dispensing process, and has the advantages of a compact structure and high dispensing efficiency.

A device for the thorough delivery of liquid medicine in an intravenous (IV) delivery system. The device consists of a negative pressure chamber filled with saline solution that is used to flush all of the residual liquid medicine from a secondary liquid medicine delivery tube. The negative pressure chamber sits below the drip chamber attached to the secondary medicine bag and is attached to the secondary medicine delivery tube in such a way that when the liquid medicine from the delivery tube has flowed below the negative pressure chamber, the negative pressure chamber releases the stored saline to flush the liquid medicine from the secondary liquid medicine delivery tube.